Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Metabolic fate of the carboxyl-carbon of valine

Conference · · J. Nucl. Med.; (United States)
OSTI ID:6844037
Although several C-11-carboxyl-labeled amino acids show promise for clinical use, few detailed biokinetic studies have been reported. Such information is necessary for the calculation of comprehensive radiation absorbed doses and may reveal additional clinical uses. The authors have collected data in mice at intervals between 1 and 90 m after i.v. injection of D,L-, L-, or D-valine for 22 whole organs or tissue samples and for CO/sub 2/ and urinary excretion. The enantiomers were cleanly separated by HPLC, but studies with the D,L- mixture were also done as additional assurance of purity for the separation (i.e., (D+L)/2=D,L). Elimination of C-11 from L-valine is restricted to the approx. =25% of injected activity (IA) observed as exhaled CO/sub 2/, the production of which appears completed in approx. =15 m, the exhalation in approx. =100m. The remaining 75% IA is available for incorporation directly into proteins or into coenzyme-A after deamination to 2-oxoisovalerate. The approx. =25% IA from D-valine that appears to be retained in the body probably is not converted to L-valine since virtually no CO/sub 2/ is recovered. The pancreatic content of approx. =8% of retained activity (RA) for both L- and D- valine at 90 m suggests similar localization mechanisms for the activity remaining in the body after excretion is ended. A similar correspondence of RA is seen in most other organs, the notable exceptions being the approx. =2 to 3 times higher %RA in blood and muscle for D-valine and in small intestine for L-valine. Studies such as this offer the possibility for quantitation of isolated metabolic processes, in this case production of CO/sub 2/ from 2-oxoisovalerate formed by deamination, and for separating metabolized from non-metabolized localization of C-11 when the D-amino acid can be shown to remain undegraded.
Research Organization:
The Univ. of Chicago, Chicago, IL
OSTI ID:
6844037
Report Number(s):
CONF-840619-
Conference Information:
Journal Name: J. Nucl. Med.; (United States) Journal Volume: 25:5
Country of Publication:
United States
Language:
English